SINGAPORE (June 30): CGS-CIMB analyst Ngoh Yi Sin is maintaining “buy” on IHH Healthcare with a target price of RM6.25 ($2.03), which is based on an unchanged sum-of-the-parts (SOTP) valuation. The rating comes after the release of IHH Healthcare’s 1Q20 results on Monday. The private healthcar...

Uploaded By:  Janine Ballesteros Submitted By:  Janine Ballesteros Case Study:  No This is due t...

THE following companies saw new developments that may affect trading of their securities on Tuesday:

IHH Healthcare sank into the red for the first quarter to March, weighed down by impairment on an investment in India and foreign currency translation losses.

IHH Healthcare sank into the red for the first quarter to March, weighed down by impairment on an investment in India and foreign currency translation losses.

SINGAPORE (June 29): Private healthcare operator IHH Healthcare reported a net loss of RM319.8 million ($103.8 million) for 1Q20, from the RM89.5 million profit a year ago. This quarter’s loss was attributable to impairment on the remaining goodwill of RM400.5 million from an investment made into ...

SINGAPORE (June 23): CGS-CIMB Research is rating the medical equipment and services industry “overweight” amid the Covid-19 pandemic. In a Monday report, lead analyst Ong Khang Chuen says, “As the world grapples with Covid-19, it faces a new normal until an effective and widely-available vacci...

SINGAPORE (June 12): Given the hit to medical tourism due to measures to curb the spread of Covid-19, hospital operators are likely to be more severely impacted in 2Q, according to CGS-CIMB Research. This could adversely impact IHH Healthcare, which has 30% of its Singapore revenue contribution deri...

LOW Soon Teck, the chief financial officer (CFO) of IHH Healthcare, has quit "to pursue his own interests or other opportunities".

HEALTHCARE heavyweight IHH Healthcare on Wednesday said it has made telemedicine available across its key markets globally, including in Singapore, Malaysia, Turkey, India and Hong Kong.